CL2016001204A1 - Composiciones y métodos para la mejora de la función pulmonar. - Google Patents

Composiciones y métodos para la mejora de la función pulmonar.

Info

Publication number
CL2016001204A1
CL2016001204A1 CL2016001204A CL2016001204A CL2016001204A1 CL 2016001204 A1 CL2016001204 A1 CL 2016001204A1 CL 2016001204 A CL2016001204 A CL 2016001204A CL 2016001204 A CL2016001204 A CL 2016001204A CL 2016001204 A1 CL2016001204 A1 CL 2016001204A1
Authority
CL
Chile
Prior art keywords
compositions
improvement
methods
lung function
iodine
Prior art date
Application number
CL2016001204A
Other languages
English (en)
Inventor
Staffan Skogvall
Original Assignee
Pharmalundensis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51945878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001204(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmalundensis Ab filed Critical Pharmalundensis Ab
Publication of CL2016001204A1 publication Critical patent/CL2016001204A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICION FARMACEUTICA QUE MEJORA LA FUNCION PULMONAR QUE COMPRENDE CARBON ACTIVADO, YODO ADSORBIDO (I2) Y/O UNA SAL DE YODO ADSORBIDO Y UN INHIBIDOR DEL SIMPORTADOR SODIO/YODO; METODO PARA MEJORAR LA FUNCION PULMONAR QUE COMPRENDE LA ADMINISTRACION DE LA COMPOSICION; UN KIT
CL2016001204A 2013-11-20 2016-05-19 Composiciones y métodos para la mejora de la función pulmonar. CL2016001204A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1351373 2013-11-20

Publications (1)

Publication Number Publication Date
CL2016001204A1 true CL2016001204A1 (es) 2016-12-02

Family

ID=51945878

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001204A CL2016001204A1 (es) 2013-11-20 2016-05-19 Composiciones y métodos para la mejora de la función pulmonar.

Country Status (11)

Country Link
US (2) US9943542B2 (es)
EP (1) EP3071233B1 (es)
JP (1) JP6521968B2 (es)
KR (1) KR20160141703A (es)
CN (1) CN105873610A (es)
CL (1) CL2016001204A1 (es)
IL (1) IL245693B (es)
RU (1) RU2016123975A (es)
SA (1) SA516371143B1 (es)
WO (1) WO2015075111A1 (es)
ZA (1) ZA201603112B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024882A (en) * 1997-08-08 2000-02-15 Applied Process Technology, Inc. Process and apparatus for water decontamination
EA017359B1 (ru) * 2007-11-23 2012-11-30 Фармалунденсис Аб Способ и композиция для достижения бронхиальной релаксации
US20100272814A1 (en) * 2007-12-19 2010-10-28 Pharmalundensis Ab Method and means for producing bronchorelaxation

Also Published As

Publication number Publication date
RU2016123975A (ru) 2017-12-25
JP6521968B2 (ja) 2019-05-29
SA516371143B1 (ar) 2018-11-28
IL245693B (en) 2018-06-28
EP3071233B1 (en) 2018-11-07
JP2017500294A (ja) 2017-01-05
US20160271170A1 (en) 2016-09-22
KR20160141703A (ko) 2016-12-09
CN105873610A (zh) 2016-08-17
US20180200292A1 (en) 2018-07-19
ZA201603112B (en) 2017-08-30
IL245693A0 (en) 2016-06-30
EP3071233A1 (en) 2016-09-28
US9943542B2 (en) 2018-04-17
WO2015075111A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
CY1122695T1 (el) Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
CL2016002772A1 (es) Composiciones de insulina de rápida acción
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
CY1119042T1 (el) Υποκατεστημενες ξανθινες και μεθοδοι χρησης αυτων
DK3330259T3 (da) 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591137A1 (ru) Ингибиторы mk2 и их применения
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
EA202090683A3 (ru) Способы и композиции для лечения рака
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
BR112019001980A2 (pt) inibidor de ido1 e método de preparação e aplicação do mesmo
CY1120535T1 (el) Δοτες νιτροξυλιου με βελτιωμενο θεραπευτικο δεικτη
EA201790380A1 (ru) Ингибиторы mk2 и их применения
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
MA40998A (fr) Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
AR098168A1 (es) Formulación estable de insulina glulisina
MX2017002610A (es) INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
BR112015032526A2 (pt) composições anticaspa e métodos de uso das mesmas
BR112017004925A2 (pt) composição e método